TY - JOUR
T1 - Loss of appetite in patients with cancer
T2 - an update on characterization, mechanisms, and palliative therapeutics
AU - Haemmerle, Robert J.
AU - Jatoi, Aminah
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Purpose of review Over the past year, loss of appetite in patients with cancer has continued to be an area of active investigation. This review provides an update of recently published findings. Recent findings Despite the emergence of new cancer therapeutic agents, this symptom of loss of appetite continues to trouble patients, and it continues to be associated with poor survival. Recent preclinical research promises to lead to newer approaches and newer, more effective palliative agents. Recent clinical research shows that agents such as olanzapine, anamorelin, and cannabis either do or might palliate this symptom. Summary Loss of appetite in patients with cancer remains an important area of clinical and research focus. Recent published data provide greater clarity with respect to how to palliate this symptom. Today, although clinicians have more options to palliate cancer-associated loss of appetite than ever before, questions remain unanswered about how to palliate this symptom optimally and how to improve the quality of life of patients who suffer from it.
AB - Purpose of review Over the past year, loss of appetite in patients with cancer has continued to be an area of active investigation. This review provides an update of recently published findings. Recent findings Despite the emergence of new cancer therapeutic agents, this symptom of loss of appetite continues to trouble patients, and it continues to be associated with poor survival. Recent preclinical research promises to lead to newer approaches and newer, more effective palliative agents. Recent clinical research shows that agents such as olanzapine, anamorelin, and cannabis either do or might palliate this symptom. Summary Loss of appetite in patients with cancer remains an important area of clinical and research focus. Recent published data provide greater clarity with respect to how to palliate this symptom. Today, although clinicians have more options to palliate cancer-associated loss of appetite than ever before, questions remain unanswered about how to palliate this symptom optimally and how to improve the quality of life of patients who suffer from it.
KW - anorexia
KW - cancer
KW - loss of appetite
UR - http://www.scopus.com/inward/record.url?scp=85165934550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165934550&partnerID=8YFLogxK
U2 - 10.1097/SPC.0000000000000669
DO - 10.1097/SPC.0000000000000669
M3 - Review article
C2 - 37499060
AN - SCOPUS:85165934550
SN - 1751-4258
VL - 17
SP - 168
EP - 171
JO - Current opinion in supportive and palliative care
JF - Current opinion in supportive and palliative care
IS - 3
ER -